A Year After Yeztugo, This HIV Prevention Shot Is Changing How People Think About PrEP
One year after the FDA approved Yeztugo, the first twice-yearly injectable medication for HIV prevention, doctors are beginning to see what long-term adoption looks like beyond clinical trials.
For many people considering PrEP, remembering a daily pill has long been one of the biggest hurdles. Yeztugo replaces that routine with two injections a year, offering another option for people who want protection without a daily reminder.
Read the full story published on Gayety here.